Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0IGA.L Stock Summary
Top 10 Correlated ETFs
0IGA.L
In the News
0IGA.L Financial details
Company Rating
Neutral
Market Cap
127.38M
Income
-757.2M
Revenue
1.05B
Book val./share
12.51
Cash/share
2.15
Dividend
-
Dividend %
-
Employees
1.6K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-0.14
Forward P/E
0.7
PEG
-0.01
P/S
0.1
P/B
0.12
P/C
1.19
P/FCF
-0.43
Quick Ratio
-
Current Ratio
-
Debt / Equity
1.33
LT Debt / Equity
0.69
-
-
EPS (TTM)
-14.83
EPS next Y
3.67
EPS next Q
-0.83
EPS this Y
251.9%
EPS next Y
-124.77%
EPS next 5Y
-93.19%
EPS last 5Y
NAN%
Revenue last 5Y
-1.05%
Revenue Q/Q
2.26%
EPS Q/Q
-81.3%
-
-
-
-
SMA20
-
SMA50
50%
SMA100
50%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-71%
ROC
-
Gross Margin
22%
Oper. Margin
-18%
Profit Margin
-72%
Payout
-
Shs Outstand
52.2M
Shs Float
50.07M
-
-
-
-
Target Price
-
52W Range
1.48-13.4182
52W High
-80.29%
52W Low
+156.2%
RSI
52
Rel Volume
0.37
Avg Volume
19.43K
Volume
7.13K
Perf Week
2.48%
Perf Month
50.71%
Perf Quarter
-10.11%
Perf Half Y
-19.94%
-
-
-
-
Beta
1.216
-
-
Volatility
0.05%, 0.49%
Prev Close
-1.08%
Price
2.562
Change
0.87%
0IGA.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 21.48 | 29.51 | 33.15 | 22.31 | 20.49 | |
Net income per share | 1.06 | 5.79 | 4.1 | -4.22 | -14.85 | |
Operating cash flow per share | 3.65 | 10.17 | 5.99 | -0.68 | -4.03 | |
Free cash flow per share | 1.96 | 7.5 | 1.8 | -7.86 | -5.04 | |
Cash per share | 3.26 | 11.79 | 10.77 | 13 | 2.18 | |
Book value per share | 21.14 | 27.46 | 30.12 | 27.7 | 12.68 | |
Tangible book value per share | 1.55 | 9.81 | 14.62 | 8.8 | 12.68 | |
Share holders equity per share | 21.14 | 27.46 | 30.12 | 27.7 | 12.68 | |
Interest debt per share | 16.58 | 17.22 | 16.36 | 28.92 | 18.76 | |
Market cap | 2.76B | 5.3B | 2.41B | 578.66M | 121.86M | |
Enterprise value | 3.43B | 5.59B | 2.71B | 1.36B | 887.66M | |
P/E ratio | 50.61 | 17.37 | 11 | -2.73 | -0.16 | |
Price to sales ratio | 2.49 | 3.41 | 1.36 | 0.52 | 0.12 | |
POCF ratio | 14.67 | 9.89 | 7.54 | -16.97 | -0.59 | |
PFCF ratio | 27.28 | 13.42 | 25.13 | -1.47 | -0.47 | |
P/B Ratio | 2.53 | 3.66 | 1.5 | 0.42 | 0.19 | |
PTB ratio | 2.53 | 3.66 | 1.5 | 0.42 | 0.19 | |
EV to sales | 3.1 | 3.59 | 1.53 | 1.22 | 0.85 | |
Enterprise value over EBITDA | 13.72 | 9.17 | 5.29 | -136.25 | -20.69 | |
EV to operating cash flow | 18.23 | 10.42 | 8.46 | -39.95 | -4.3 | |
EV to free cash flow | 33.9 | 14.14 | 28.2 | -3.46 | -3.44 | |
Earnings yield | 0.02 | 0.06 | 0.09 | -0.37 | -6.24 | |
Free cash flow yield | 0.04 | 0.07 | 0.04 | -0.68 | -2.12 | |
Debt to equity | 0.75 | 0.61 | 0.53 | 1.02 | 1.33 | |
Debt to assets | 0.35 | 0.31 | 0.29 | 0.45 | 0.47 | |
Net debt to EBITDA | 2.68 | 0.47 | 0.58 | -78.38 | -17.85 | |
Current ratio | 3.17 | 3.11 | 3.4 | 0.98 | 1.04 | |
Interest coverage | 3.56 | 18.05 | 13.45 | -4.27 | -1.78 | |
Income quality | 3.45 | 1.76 | 1.46 | 0.16 | 0.27 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.14 | 0.05 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.2 | 0.13 | 0.13 | 0.17 | 0.1 | |
Intangibles to total assets | 0.43 | 0.32 | 0.28 | 0.3 | 0 | |
Capex to operating cash flow | -0.46 | -0.26 | -0.7 | 10.54 | 0.25 | |
Capex to revenue | -0.08 | -0.09 | -0.13 | -0.32 | -0.05 | |
Capex to depreciation | -0.78 | -1.23 | -1.77 | -2.41 | -0.4 | |
Stock based compensation to revenue | 0.02 | 0.03 | 0.02 | 0.04 | -0.26 | |
Graham number | 22.43 | 59.8 | 52.73 | 51.3 | 65.1 | |
ROIC | 0.05 | 0.16 | 0.11 | -0.05 | -0.12 | |
Return on tangible assets | 0.04 | 0.16 | 0.1 | -0.1 | -0.41 | |
Graham Net | -14.62 | -9.26 | -7.26 | -16.62 | -14.96 | |
Working capital | 469.9M | 811.4M | 895.9M | -18.5M | 28.2M | |
Tangible asset value | 80M | 517.2M | 782M | 440.7M | 649.3M | |
Net current asset value | -552.6M | -240.3M | -76.3M | -568.2M | -506.1M | |
Invested capital | 0.75 | 0.61 | 0.53 | 1.02 | 1.33 | |
Average receivables | 268.9M | 253.1M | 254.9M | 219.05M | 175.1M | |
Average payables | 87.75M | 115.45M | 132.5M | 116.2M | 107.85M | |
Average inventory | 214.15M | 264.75M | 325.75M | 347.6M | 339.8M | |
Days sales outstanding | 90.85 | 54.18 | 57.4 | 52 | 66.44 | |
Days payables outstanding | 74.03 | 89.98 | 58.54 | 50.34 | 54.11 | |
Days of inventory on hand | 173.75 | 202.96 | 156.45 | 170.58 | 158.63 | |
Receivables turnover | 4.02 | 6.74 | 6.36 | 7.02 | 5.49 | |
Payables turnover | 4.93 | 4.06 | 6.24 | 7.25 | 6.75 | |
Inventory turnover | 2.1 | 1.8 | 2.33 | 2.14 | 2.3 | |
ROE | 0.05 | 0.21 | 0.14 | -0.15 | -1.17 | |
Capex per share | -1.69 | -2.68 | -4.19 | -7.18 | -1.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.63 | 3.29 | 6.66 | 5.22 | 5.33 | |
Net income per share | -1.76 | -3.65 | -5.15 | -5.08 | -0.95 | |
Operating cash flow per share | 1.86 | -3.67 | -2.26 | 1.16 | 0.62 | |
Free cash flow per share | 1.39 | -3.97 | -2.5 | 0.92 | 0.4 | |
Cash per share | 13.05 | 8.69 | 1.75 | 5.12 | 2.15 | |
Book value per share | 27.81 | 23.96 | 18.86 | 13.46 | 12.51 | |
Tangible book value per share | 8.83 | 7.48 | 2.87 | 13.46 | 12.51 | |
Share holders equity per share | 27.81 | 23.96 | 18.86 | 13.46 | 12.51 | |
Interest debt per share | 28.58 | 28.33 | 18.51 | 17.14 | 17.07 | |
Market cap | 576.35M | 521.83M | 374.67M | 173.01M | 123.52M | |
Enterprise value | 1.36B | 1.51B | 1.21B | 965.11M | 889.32M | |
P/E ratio | -1.64 | -0.71 | -0.36 | -0.16 | -0.62 | |
Price to sales ratio | 1.74 | 3.16 | 1.11 | 0.64 | 0.45 | |
POCF ratio | 6.21 | -2.84 | -3.28 | 2.88 | 3.85 | |
PFCF ratio | 8.33 | -2.62 | -2.95 | 3.65 | 5.97 | |
P/B Ratio | 0.42 | 0.43 | 0.39 | 0.25 | 0.19 | |
PTB ratio | 0.42 | 0.43 | 0.39 | 0.25 | 0.19 | |
EV to sales | 4.11 | 9.12 | 3.57 | 3.57 | 3.22 | |
Enterprise value over EBITDA | -83.44 | -13.45 | 25.6 | 39.55 | -78.01 | |
EV to operating cash flow | 14.66 | -8.19 | -10.54 | 16.09 | 27.7 | |
EV to free cash flow | 19.66 | -7.57 | -9.5 | 20.36 | 42.96 | |
Earnings yield | -0.15 | -0.35 | -0.7 | -1.52 | -0.4 | |
Free cash flow yield | 0.12 | -0.38 | -0.34 | 0.27 | 0.17 | |
Debt to equity | 1.02 | 1.17 | 0.95 | 1.24 | 1.33 | |
Debt to assets | 0.45 | 0.48 | 0.42 | 0.46 | 0.47 | |
Net debt to EBITDA | -48.09 | -8.79 | 17.65 | 32.46 | -67.18 | |
Current ratio | 0.98 | 0.98 | 1.08 | 1.07 | 1.04 | |
Interest coverage | -3.94 | -7.22 | 0.45 | -0.21 | -1.89 | |
Income quality | -1.05 | 1.01 | 0.44 | -0.23 | -0.65 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.17 | 0.24 | 0.08 | 0.05 | 0.11 | |
Intangibles to total assets | 0.3 | 0.28 | 0.37 | 0 | 0 | |
Capex to operating cash flow | -0.25 | 0.08 | 0.11 | -0.21 | -0.36 | |
Capex to revenue | -0.07 | -0.09 | -0.04 | -0.05 | -0.04 | |
Capex to depreciation | -0.57 | -0.44 | -0.38 | -0.43 | -0.37 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.02 | 0.07 | -0.02 | |
Graham number | 33.22 | 44.33 | 46.77 | 39.24 | 16.39 | |
ROIC | -0.03 | -0.06 | 0.01 | 0 | -0.02 | |
Return on tangible assets | -0.04 | -0.09 | -0.19 | -0.14 | -0.03 | |
Graham Net | -16.69 | -20.12 | -14.58 | -11.42 | -14.76 | |
Working capital | -18.5M | -21.5M | 54.2M | 47.4M | 28.2M | |
Tangible asset value | 440.7M | 375.5M | 145.3M | 697.2M | 649.3M | |
Net current asset value | -568.2M | -553M | -475.1M | -484.5M | -506.1M | |
Invested capital | 1.02 | 1.17 | 0.95 | 1.24 | 1.33 | |
Average receivables | 175.25M | 157.55M | 223M | 253.3M | 203.75M | |
Average payables | 103.65M | 113.85M | 116.25M | 110.5M | 112.45M | |
Average inventory | 448.5M | 359.3M | 361.1M | 354.2M | 341.5M | |
Days sales outstanding | 43.33 | 84.98 | 77.27 | 72.03 | 62.15 | |
Days payables outstanding | 39.29 | 64.95 | 47.16 | 56.01 | 50.04 | |
Days of inventory on hand | 133.12 | 192.39 | 154.27 | 175.97 | 146.68 | |
Receivables turnover | 2.08 | 1.06 | 1.16 | 1.25 | 1.45 | |
Payables turnover | 2.29 | 1.39 | 1.91 | 1.61 | 1.8 | |
Inventory turnover | 0.68 | 0.47 | 0.58 | 0.51 | 0.61 | |
ROE | -0.06 | -0.15 | -0.27 | -0.38 | -0.08 | |
Capex per share | -0.47 | -0.3 | -0.25 | -0.24 | -0.22 |
0IGA.L Frequently Asked Questions
What is Emergent BioSolutions Inc. stock symbol ?
Emergent BioSolutions Inc. is a US stock , located in Gaithersburg of Md and trading under the symbol 0IGA.L
What is Emergent BioSolutions Inc. stock quote today ?
Emergent BioSolutions Inc. stock price is $2.562 today.
Is Emergent BioSolutions Inc. stock public?
Yes, Emergent BioSolutions Inc. is a publicly traded company.